WO1993025269A1 - Ambulatory energized container system - Google Patents
Ambulatory energized container system Download PDFInfo
- Publication number
- WO1993025269A1 WO1993025269A1 PCT/US1993/005736 US9305736W WO9325269A1 WO 1993025269 A1 WO1993025269 A1 WO 1993025269A1 US 9305736 W US9305736 W US 9305736W WO 9325269 A1 WO9325269 A1 WO 9325269A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ambulatory
- bladder
- gas
- solution
- container system
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J7/00—Apparatus for generating gases
- B01J7/02—Apparatus for generating gases by wet methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/148—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons flexible, e.g. independent bags
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M2005/1401—Functional features
- A61M2005/1404—Keep vein-open rate [KVO], i.e. low flow rate
Definitions
- An object of the invention is to provide a new ambulatory energized container KVO system which is effective for an advantageous period of time.
- Another object of the invention is to provide a new ambulatory self-energized KVO system which is lightweight and which is disposable in its entirety after being used.
- a further object of the invention is to provide a new ambulatory energized container system having a combination bladder and sleeve member which while being flexible, maintains an enhanced degree of structural integrity while being pressurized for an extended period of time, for example for greater than 48 hours.
- An additional object of the invention is to provide a new design for construction of a new combination sleeve and bladder member of an energized container system of the invention, which design is advantageously forgiving of deviations from manufacturing specifications during lamination procedures involved in construction of the combination sleeve and bladder member.
- the present invention is for an ambulatory energized container system suitable for developing a continuous pressure on, and flow of, a solution from a flexible bag for solution into a patient's indwelling vein access device, for example sufficient for keeping the patient's vein open even though medication may be administered through the access device only intermittently.
- the ambulatory energized container system comprises a combination sleeve and bladder member (combination member).
- the combination member has a bladder portion and a sleeve portion.
- a flexible bag for solution can be inserted into the sleeve portion.
- the flexible bag for the solution has an outlet port suitable for connection to a tube set connectable between the outlet port of the bag and the patient's vein access device.
- the flexible bag for solution optionally may be associated with said sleeve portion so as to be essentially or completely non-removable therefrom.
- the bladder portion of the combination member is made of a flexible plastic material, for example a multilayer laminated material, and is expandable upon introduction of a gas into the bladder portion.
- the sleeve portion of the combination member is made of a flexible material, for example a multilayer laminated material.
- the sleeve portion is designed to receive therein, or to have integrally associated therewith, the flexible bag for solution in a position in the sleeve portion alongside the bladder portion of the combination member such that upon expansion of the bladder portion upon introduction of gas into the bladder portion, continuous pressure is applied through the sleeve portion to the flexible bag for solution when the bag has solution therein.
- the bladder portion of the combination member also has associated with it barrier means for containing hquid and gas.
- Gas-generating, reactive, chemical means are disposed within the barrier means in an ambulatory energized container system of the invention. Additionally, the ambulatory energized container system includes segregating means for segregating reactive components of the gas- generating reactive chemical means, for example two reactive chemical compounds, from one another prior to chemical reaction.
- Activation of an ambulatory energized container system of the invention involves removal of the segregating means, for example by manual manipulation or breaking at least a portion thereof, which results in a chemical reaction and the formation of a volume of gas sufficient to expand the bladder portion thereby exerting a continuing pressure on the flexible bag for solution inserted in the sleeve member (or integral with the sleeve member), the bag having solution therein.
- the barrier means for containing liquid and gas can comprise a first sealed expandable barrier container which is permeable to gas and which contains the gas-generating reactive chemical means.
- This first barrier container is disposed within the bladder portion of the combination member and typically serves to contain moisture and debris formed during reaction of the gas-generating chemical means.
- the barrier means for containing liquid and gas may also comprise a second sealed expandable barrier container which is substantially gas-impermeable.
- a second sealed expandable barrier container may be employed in embodiments of the invention wherein the walls of the bladder portion itself are not designed to contain a pressurized gas inside the bladder portion over an extended period of time, for example for at least 48 hours, and such containment is desired for a particular patient procedure.
- such a second sealed expandable barrier container can be dispensed with, for example, where the walls of the bladder portion themselves are designed to be substantially or essentially gas-impermeable or where the period of time for which the pressure of a gas in the bladder portion needs to be maintained does not have to be very long, for example under two hours.
- the flexible plastic material of the walls of the bladder portion comprises at least two laminated layers (of plastic material) of differing material stiffness wherein the layers are arranged, looking in a direction outwardly from the interior of the bladder portion, in order of decreasing material stiffness.
- the layer of the composite laminate having the greatest material stiffness (or highest elastic modulus) lies closest to the interior of the bladder portion.
- the layers are arranged, again looking in a direction outwardly from the interior of the bladder portion, in order of decreasing material stiffness.
- the layer of the composite laminate of at least the wall of the sleeve portion lying closest to the interior of the bladder portion has the greatest material stiffness (or highest elastic modulus).
- FIG. 1 is a diagrammatic, exploded view of an ambulatory energized container KVO system illustrating a preferred embodiment of the invention
- FIG. 2 is a perspective view of the combination sleeve and bladder member of the system of FIG. 1 after insertion of a flexible bag of saline solution to be infused into the sleeve portion of the combination sleeve and bladder member, after spiking of the outlet port, and after pressurization of the bladder portion ⁇
- FIG. 3 is a longitudinal section taken through the deflated sleeve and bladder member, including the separate barrier means sealed therein, prior to insertion of a flexible bag of saline solution into the sleeve portion thereof and prior to pressurization of the bladder portion thereof;
- FIG. 4 is a longitudinal section similar to FIG. 3 after insertion of a flexible bag of saline solution into the sleeve portion of the deflated sleeve and bladder member, also prior to pressurization thereof;
- FIG. 5 is a longitudinal section similar to FIGS. 3 and 4 after pressurization of the bladder portion of the sleeve and bladder member;
- FIG. 5 A is a longitudinal section similar to FIG. 5, but excluding the separate barrier means sealed within the bladder portion of the sleeve and bladder member;
- FIG. 6 is an enlarged longitudinal section of a perspective view of the restrictor during normal minimal infusing flow rate of saline solution therethrough;
- FIG. 7 is a view similar to FIG. 6 with the bypass open, as during a restrictor and indwelling catheter flushing operation;
- FIG. 8 is an enlarged front elevational view of the deflated combination sleeve and bladder member prior to insertion of a flexible bag of saline solution in the sleeve portion thereof and prior to pressurization of the bladder portion thereof;
- FIG. 9 is a vertical sectional view through the combination sleeve and bladder member and taken generally along line 9-9 of FIG. 8;
- FIG. 10 is an enlarged fragmentary sectional view taken through a second embodiment of the bladder member wherein the barrier means is laminated or coated to the inner surface thereof;
- FIG. 11 is an enlarged fragmentary sectional view similar to FIG. 10 but taken through a third embodiment of the bladder member wherein the barrier means is embedded therein;
- FIG. 12 is a transverse section taken through an inflated sleeve and bladder member after pressurization showing multilayer laminates for the walls of the bladder portion and sleeve portion of the combination sleeve and bladder member;
- FIG. 13 shows in schematic form optimal placement of seal bars for making side-edge welds in relation to a top weld during lamination to form a combination sleeve and bladder member;
- FIG. 14 shows in schematic form placement of seal bars for making side-edge welds in relation to a top weld during lamination to form a combination sleeve and bladder member to produce side-edge welds which cross the midpoints of the corner curves from a top weld;
- FIG. 15 shows in schematic form placement of seal bars for making side-edge welds in relation to a top weld during lamination to form a combination sleeve and bladder member which placement results in a 90 degree angle at one of the corners;
- FIG. 16 shows in schematic form a placement of seal bars for making side-edge welds in relation to a top weld during lamination to form a combination sleeve and bladder member in which placement results in equal cross over angles at both sides as a result of employing 45 degree angles at the side-most portions of the top seals;
- FIG. 17 is similar to FIG. 16 except that the seal bars for making the side-edge welds in relation to a top weld have been shifted to the right.
- the new and improved ambulatory energized container KVO system is effective for an advantageous period of time.
- the energized container system of the invention is characterized by a chemically pressurized bladder which exerts a continuing pressure on a flexible bag of solution to be administered to a patient, for example saline solution, to force the solution therefrom through a restrictor at a resulting low rate through the patient's indwelling vein access device to maintain patency of the vein access site, the pressure of the solution at the site being slightly greater than the pressure within the vein.
- the restrictor has associated therewith a reseal for administering medication to the patient intermittently and a manually operable bypass for easily flushing the reseal, restrictor and vein access device after each administration of medication.
- the bladder portion of the combination bladder and sleeve member is made of a flexible plastic material, for example a multilayer laminated material, and is expandable upon introduction of a gas into the bladder portion.
- the bladder can be formed of a relatively tough plastic such as polyurethane, polyvinylidene chloride, fabric reinforced polyurethane, shore 90A durometer material and the Uke and combinations thereof. These materials are somewhat permeable to the pressurized gas formed therein but are adequate for use in those applications having a short term usage.
- gas barrier means which is relatively impermeable to the pressurized gas, is associated with the bladder whereupon the bladder is able to sustain its pressure against the bag of solution for at least forty-eight hours.
- Such gas barrier means may be in the form of a separate sealed balloon, a barrier film laminated to the bladder portion itself, or a coating on the bladder portion.
- a further gas-permeable, moisture-and-debris barrier means for example in the form of a sealed packet, is provided within the bladder with normally segregated reactive chemicals being disposed therein. Suggested chemicals are loose sodium bicarbonate and a frangible vial of citric acid which is readily breakable by manual manipulation through the flexible bladder and moisture-and-debris barrier means to initiate the chemical reaction and pressurize the bladder portion by the formation of a gas such as carbon dioxide.
- the flexible bag of solution to be infused for example saline solution, for this ambulatory energized KVO system is inserted into the sleeve portion of the combination sleeve and bladder member in side-by-side relationship therewith, the sleeve and bladder member being attachable to the patient's wearing apparel, whether a hospital gown or street clothes.
- the sleeve and bladder member is also provided with an "EMPTY" indicator.
- the new and improved ambulatory self-energized KVO system of the invention is lightweight and, in its entirety, is disposable after being used.
- the new and improved energized container system is characterized by a sleeve and bladder member, with the sleeve portion being adapted to receive (or having integrally associated therewith) a bag for solution such as saline solution to be continuously infused at a rriinimal flow rate and with the bladder portion adapted to be pressurized by a selectively initiated chemical reaction therein, and by a tube set including ar air filter and a restrictor having a reseal for intermittent medication ads and a bypass for flushing thereafter.
- the bladder portion provides a high volume, high pressure gas reservoir, and maintains a nearly constant pressure on the flexible bag of solution during up to a two hour period or longer in which the solution is being delivered to the patient.
- the bladder portion which provides a high volume, high pressure gas reservoir, is characterized by a rugged, expandable outer plastic film and by an inner, sealed, gas impermeable balloon, which bladder portion maintains a nearly constant pressure on the flexible bag of solution such as saline during at least a forty-eight hour period during which the solution is being delivered to the patient.
- the bladder portion has a gas barrier lamination or coating associated therewith.
- the new and improved energized container system is small enough and Ught enough to be attached to a patient's clothing and has an "EMPTY" indicator provided on the sleeve and bladder member.
- one embodiment of the invention includes a combination sleeve and bladder member 12 which is formed of a relatively rugged and tough plastic film material which is flexible, expandable and has a relatively high tensile strength, such as polyurethane, JPS Elastomerics, MP-890, with a thickness of 20 mil and a durometer of Shore 90A.
- the ambulatory, self-energized container KVO (keep vein open) infusion system of the invention also includes a flexible bag 13 of solution, such as saline solution, which is to be infused at a continuous minimal flow rate into a patient through an indwelling vein access device, such as a catheter (not shown), to permit the administration of medication intermittently.
- This continuous low rate of infusion at a positive pressure slightly greater than the pressure within the vein maintains the patency of the access site between medication administrations and also prevents any back flow of blood into the system.
- This system is designed to be effective over a period of forty-eight hours or more with the bag 13 of saline solution having a volume of only 100 ml.
- the bag 13 is provided with an outlet port 14.
- the bag 13 is shown in FIGS. 1 and 2 is also shown with a reseal port 16 for making additives to the contents of the sealed bag 13, this reseal port is not a necessary element of this KVO infusion system, the outlet port 14 being all that is necessary.
- the system further includes a tube set 18 having a pin 20 for spiking the outlet port 14 of the bag 13 of saline solution, an air elimination steriUzing filter 22, such as a .2 micron FILTERTEK filter, a low flow capillary restrictor 24 (to be described in greater detail hereinafter), a J-loop 26 for connection to the patient's indweUing vein access device (catheter), suitable lengths of interconnecting plastic tubing 28, such as .043 x .138 size tubing, and suitable connectors, as needed.
- an air elimination steriUzing filter 22 such as a .2 micron FILTERTEK filter
- a low flow capillary restrictor 24 to be described in greater detail hereinafter
- J-loop 26 for connection to the patient's indweUing vein access device (catheter)
- suitable lengths of interconnecting plastic tubing 28 such as .043 x .138 size tubing, and suitable connectors, as needed.
- the combination sleeve and bladder member 12 is formed by three generally rectangular sheets 30, 32 and 34 of plastic, such as polyurethane or polyurethane-coated fabric, which overlie one another and are sealed together, as by welding, in a manner to be described hereinafter, to provide a sleeve portion 36 and a bladder portion 38.
- plastic such as polyurethane or polyurethane-coated fabric
- the side edges of all three sheets 30, 32 and 34 are welded (sealed) together, as at 40 and 42 in Fig.
- sheets 30 and 32 define the four- sided sealed bladder portion 38 with sheet 30 serving as the outer side wall thereof and sheet 32 serving as the inner side wall thereof and whereby sheets 32 and 34 define the sleeve portion 36 which is partially sealed at its upper end and fully open at its lower end with sheet 34 serving as the outer side wall of the sleeve portion 36 and sheet 32 serving double- duty as the inner side wall thereof as weU as the inner side wall of the bladder portion 38.
- the four outer ends 89 and 91 of the two first-step bladder welds 44 and 46, respectively, are incUned inwardly, preferably at a 45 degree angle from the remaining horizontal portion of the welds, toward the center of the sleeve and bladder member 12 and into sealed engagement with the two second-step side welds 40 and 42.
- An opening 48 for attaching any one of a number of known hangers is provided in the upper edges of sheets 30 and 32, at the center thereof, so that the sleeve and bladder member 12 may be readily attached to a patient's clothing, be it a hospital gown or street wear.
- the combination sleeve and bladder member 12 is formed by three generally rectangular overlying sheets 30, 32 and 34 of plastic with the side edges of all three sheets being sealed together to form two three-layer seals (welds) and with two adjacent sheets 30 and 32 of the three sheets being sealed together along the bottom edges thereof (as at 44) and along the upper portions thereof (as at 46) spaced below the upper edges thereof to form two two-layer seals (welds).
- Each of the two-layer seals extends outwardly (as at 89 and 91) from each of the bottom edges and upper portions of the two adjacent sheets toward each of the side edges of the two adjacent sheets at essentially, preferably exactly, 45 degree angles from the remaining horizontal portions of the two-layer seals (welds).
- the resulting combination sleeve and bladder member 12 has a sealed bladder portion 38 of the combination member 12, the sleeve portion 36 of the combination member 12 being defined by the two adjacent sheets which are not sealed together at their tops and bottoms, the middle of the three sheets defining both an inner side wall 32 of the sleeve portion 36 and an inner side wall 32 of the bladder portion 38, the sleeve and bladder portions being disposed in side- by-side relationship.
- the seals will not overlap with both of the top and bottom seals (top only shown) and an open bladder will be produced.
- Fig. 14 by targeting the side-edge seals (welds) at the midpoints 92 of the corner curves, the stress can be minimized since the incidence angles at these points are 45 degrees.
- an incident angle can approach a 90 degree angle (shown at 94 on left side of Fig. 15) and therefore provide no benefit over a straight seal bar.
- FIG. 16 shows the 45 degree angle configuration.
- a 45 degree angle (or 45 degree chamfer), shown at 93 in Figs. 16 and 17, is preferred from the standpoint of reducing stress on the corner seals.
- UtiUzation of a 45 degree angle (chamfer) eliminates the variabUity due to movement of the film sheets, to be laminated together, below the manufacturing dies.
- Fig. 16 shows the die cross-over at the nominal design placement. The angles made by the top die crossing both of the chamfers are both 45 degrees. From Fig.
- the sleeve portion 36 of the combination member 12 is of a size to receive the 100 cc flexible bag 13 of saUne solution when inserted therein from the bottom whereupon the bag 13 is disposed in side-by-side relationship with the bladder portion 3 S, as shown in Fig. 4, prior to pressurization thereof.
- the outlet port 14 thereon depends from the sleeve and bladder member 12 and is readily accessible for spiking of same. Insertion of the bag 13 from the top of the sleeve and bladder member 10 is prevented by the inwardly directed weld extensions 40a and 42a.
- the bladder portion 38 is to be pressurized so that it defines a high volume, high pressure gas reservoir which is adapted to exert a continuing pressure on the bag 13 of saline solution so as to infuse the 100 cc's of solution into a patient over a given period.
- gas-impermeable barrier means is ulustrated in Figs. 2-5, 8 and 9.
- This barrier means is in the form of a sealed balloon 50 which is initially deflated, folded and sealed within the bladder portion 38 and which is formed of a 3 mil fUm of polyvinyUdene chloride, for example available commercially from Dow Chemical as Saranex 15.
- a further gas-permeable, moisture-and-debris barrier means in the form of a sealed, folded packet 52 formed of a non-woven polypropylene fiber material, for example available commercially as Tyvek, is sealed within the baUoon 50.
- a frangible ampoule 54 Disposed within the packet 52 are reactive chemicals such as sodium bicarbonate and citric acid, which chemicals are normally segregated for example by encasing the citric acid in a frangible ampoule 54.
- reactive chemicals such as sodium bicarbonate and citric acid
- citric acid controls the volume of gas generated, excess sodium bicarbonate may be present in the packet 52 and such excess is desirable.
- the ampoule 54 may easily be broken by manually manipulating same through the flexible bladder portion 38, the balloon 50, and the packet 52.
- the packet 52 which is permeable to the carbon dioxide gas formed by the chemical reaction following breaking of the ampoule 54, serves as a barrier to contain most of the moisture and debris such as other by-products of the chemical reaction and all fragments of the ampoule 54 which could have sharp edges.
- the volume of gas formed passes through the packet 52 and inflates the balloon 50 which then physicaUy expands the flexible bladder portion 38 which, in turn, exerts a continuing pressure on the flexible bag 13 of saUne solution.
- barrier means for the bladder portion 38 constitutes a laminated or coated bladder portion 38a wherein a 1 mil sheet 56 or coating of polyvinyUdene chloride, commercially known as Saran, is laminated or coated to 20 mil of polyurethane, in either of two forms.
- the layer 56 of polyvinyUdene chloride is laminated to the inner surface of a 20 mil layer 58 of polyurethane whereas in Fig. 11 the 1 mil layer 56 of polyvinyUdene chloride is laminated and embedded between two 10 mil layers 58a of polyurethane.
- the layer 56 of polyvinyUdene chloride serves as the impermeable gas barrier. With either of the latter two embodiments (Figs.
- the separate gas barrier balloon 50 is eUminated
- the two bladder-defining sheets 30 and 32 need be laminated with the layer 56 of polyvinyUdene chloride.
- the other sleeve-defining sheet 34 may comprise, for example, a single layer of polyurethane. However, in both of the latter two embodiments (Figs. 10 and 11), the barrier packet 52 is still sealed within the bladder portion 38a.
- barrier means for the bladder portion 38 consists of a laminated or coated bladder portion wherein the flexible material of the bladder and barrier means utilizes a single multilayer combination (having at least two layers).
- a single multilayer combination having at least two layers.
- many combinations of materials are suitable for creating such a multilayer bladder/barrier means.
- the materials used to make the multilayer combination are ordered such that the material closest to the gas has the highest material stiffness or elastic modulus, and the materials which can be laminated thereon are successively less stiff.
- the material forming the outermost layer, or which is furthest from the gas has the least material stiffness or elastic modulus.
- the barrier layer 56a of polyvinyUdene chloride is laminated to the outer surface of layer of fabric reinforced polyurethane 58b and to the inner surface of a layer of non-reinforced polyurethane 58c.
- the order of decreasing material stiffness is fabric reinforced polyurethane 58b, polyvinyUdene chloride 56a and non-reinforced polyurethane 58c.
- the flexible plastic material of the walls of the bladder portion 38 comprises three laminated layers (of plastic material) of differing material stiffness wherein the layers are arranged, looking in a direction outwardly from the interior 59 of the bladder portion 38, in order of decreasing material stiffness.
- the layer of the composite laminate having the greatest material stiffness (or highest elastic modulus) lies closest to the interior 59 of the bladder portion 38.
- the flexible material of the sleeve portion 36 comprises at least two laminated layers (of plastic material) of differing material stiffness, the layers being arranged, again looking in a direction outwardly from the interior 59 of the bladder portion 38, in order of decreasing material stiffness.
- the layer of the composite laminate of at least the wall 60 of the sleeve portion 36 lying closest to the interior 59 of the bladder portion 38 has the greatest material stiffness (or highest elastic modulus).
- the restrictor 24 which determines the low rate of flow of the saline solution into the patient is located in the tube set 18 at a location adjacent the patient's indwelling vein access device, such as a catheter (not shown).
- the restrictor 24 includes a housing 62 having an inlet port 64 and an offset but paraUel outlet port 66, the opposite end of which is closed by a reseal 68 which is in axial aUgnment with an outlet passage 70 of the outlet port 66.
- Two parallel passages 72 and 74 are disposed normally to the outlet passage 70 and each is in fluid communication with both the inlet port 64 at one end thereof and the outlet passage 70 at the opposite end thereof.
- the passage 72 serves as a bypass passage and has a resilient, manually operable valve member 76 disposed therein. Normally, the inner end of the bypass valve 76 is biased into its innermost position blocking the passage therefrom into the outlet passage 70.
- a glass capillary member 78 having an axial capillary passage 80 of a predetermined size is disposed in passage 74 and has 0-rings 82 sealing opposite ends thereof.
- a housing cover 84 serves to retain the bypass valve 76 and the capiUary member 78 in their respective passages 70 and 72.
- the reseal 68 is disposed at a right angle to the bypass passage 72 thereby defining a T-shaped configuration which maximizes the flushing effect within the restrictor 24 when the bypass valve 76 is open.
- the word EMPTY is imprinted on the inner sleeve side wall 32 toward the bottom thereof, as shown at 86 in Fig. 8, which imprint 86 is visible through the outer sleeve side wall 34 only when the two side walls 32 and 34 defining the sleeve portion 36 are fairly close together due to the matte finish of the outer side wall 34.
- the sleeve side walls 32 and 34 are spaced so far apart that the imprint 86 is not visible.
- the sleeve side walls 32 and 34 become closer and closer together with the imprint 86 becoming visible as the bag 13 approaches an empty condition.
- citric acid when aqueous citric acid is utilized with excess powdered sodium bicarbonate, generally 40% to 60%, preferably 50% by weight, citric acid is used with from 3.7 grams (g) to 7.0 g of sodium bicarbonate within a generally rectangular gas-permeable seald packet (moisture-and-debris barrier) having a total surface area of about 10 square inches to generate about 15 pounds per square inch gauge pressure (psig) within a 100 ml bladder portion. Typically enough 50% by weight citric acid is utilized with 7 g of sodium bicarbonate in the aforesaid 10 square inch sealed packet to provide 15 psig pressure in the aforesaid 100 ml bladder portion.
- the quantities of the components of gas-generating reactive chemical means will vary.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU46361/93A AU676183B2 (en) | 1992-06-15 | 1993-06-15 | Ambulatory energized container system |
CA002138008A CA2138008A1 (en) | 1992-06-15 | 1993-06-15 | Ambulatory energized container system |
JP6501798A JPH07507944A (en) | 1992-06-15 | 1993-06-15 | Outpatient Energize Container System |
EP93916549A EP0646032A4 (en) | 1992-06-15 | 1993-06-15 | Ambulatory energized container system. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89825992A | 1992-06-15 | 1992-06-15 | |
US898,259 | 1992-06-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993025269A1 true WO1993025269A1 (en) | 1993-12-23 |
Family
ID=25409171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1993/005736 WO1993025269A1 (en) | 1992-06-15 | 1993-06-15 | Ambulatory energized container system |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0646032A4 (en) |
JP (1) | JPH07507944A (en) |
AU (1) | AU676183B2 (en) |
CA (1) | CA2138008A1 (en) |
WO (1) | WO1993025269A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5578005A (en) * | 1993-08-06 | 1996-11-26 | River Medical, Inc. | Apparatus and methods for multiple fluid infusion |
WO1996037245A1 (en) * | 1995-05-22 | 1996-11-28 | Elan Medical Technologies Limited | Feedback-controlled liquid delivery device |
WO2013186289A1 (en) * | 2012-06-13 | 2013-12-19 | Medex | Device for injecting a liquid product comprising two half-shells rotatably mobile relative to each other |
US9662439B2 (en) | 2012-06-13 | 2017-05-30 | Medex | Controller for the automatic control of an injection device |
US11389584B2 (en) | 2017-07-06 | 2022-07-19 | Avent, Inc. | Priming system for infusion devices |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2578419Y2 (en) * | 1992-12-03 | 1998-08-13 | 株式会社パイオラックス | Continuous chemical injector |
JP5610418B2 (en) * | 2009-09-07 | 2014-10-22 | 学校法人立命館 | Substance supply device |
JP6348167B2 (en) * | 2013-03-13 | 2018-06-27 | インキューブ ラブズ, エルエルシー | Infusion system for controlled delivery of therapeutic agents |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3469578A (en) * | 1965-10-12 | 1969-09-30 | Howard R Bierman | Infusion device for ambulatory patients with flow control means |
US3847149A (en) * | 1972-03-02 | 1974-11-12 | J Murray | Hygenic douche system |
US4379453A (en) * | 1978-12-28 | 1983-04-12 | Baron Howard C | Infusion system with self-generating pressure assembly |
US4447238A (en) * | 1980-05-07 | 1984-05-08 | Instranetics, Inc. | Medical tubing holder |
US4739770A (en) * | 1986-05-21 | 1988-04-26 | Hewlett-Packard Company | Flush device |
US4947886A (en) * | 1989-04-21 | 1990-08-14 | Remote Controls, Inc. | Temperature actuated flow control device |
US5053011A (en) * | 1989-09-29 | 1991-10-01 | Harmac Medical Products, Inc. | Disposable pressure infusion system |
-
1993
- 1993-06-15 WO PCT/US1993/005736 patent/WO1993025269A1/en not_active Application Discontinuation
- 1993-06-15 AU AU46361/93A patent/AU676183B2/en not_active Ceased
- 1993-06-15 EP EP93916549A patent/EP0646032A4/en not_active Withdrawn
- 1993-06-15 CA CA002138008A patent/CA2138008A1/en not_active Abandoned
- 1993-06-15 JP JP6501798A patent/JPH07507944A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3469578A (en) * | 1965-10-12 | 1969-09-30 | Howard R Bierman | Infusion device for ambulatory patients with flow control means |
US3847149A (en) * | 1972-03-02 | 1974-11-12 | J Murray | Hygenic douche system |
US4379453A (en) * | 1978-12-28 | 1983-04-12 | Baron Howard C | Infusion system with self-generating pressure assembly |
US4447238A (en) * | 1980-05-07 | 1984-05-08 | Instranetics, Inc. | Medical tubing holder |
US4739770A (en) * | 1986-05-21 | 1988-04-26 | Hewlett-Packard Company | Flush device |
US4947886A (en) * | 1989-04-21 | 1990-08-14 | Remote Controls, Inc. | Temperature actuated flow control device |
US5053011A (en) * | 1989-09-29 | 1991-10-01 | Harmac Medical Products, Inc. | Disposable pressure infusion system |
Non-Patent Citations (1)
Title |
---|
See also references of EP0646032A4 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5578005A (en) * | 1993-08-06 | 1996-11-26 | River Medical, Inc. | Apparatus and methods for multiple fluid infusion |
WO1996037245A1 (en) * | 1995-05-22 | 1996-11-28 | Elan Medical Technologies Limited | Feedback-controlled liquid delivery device |
WO2013186289A1 (en) * | 2012-06-13 | 2013-12-19 | Medex | Device for injecting a liquid product comprising two half-shells rotatably mobile relative to each other |
US9662439B2 (en) | 2012-06-13 | 2017-05-30 | Medex | Controller for the automatic control of an injection device |
US9827370B2 (en) | 2012-06-13 | 2017-11-28 | Medex | Device for injecting a liquid product comprising two half-shells rotatably mobile relative to each other |
US11389584B2 (en) | 2017-07-06 | 2022-07-19 | Avent, Inc. | Priming system for infusion devices |
Also Published As
Publication number | Publication date |
---|---|
EP0646032A1 (en) | 1995-04-05 |
AU4636193A (en) | 1994-01-04 |
AU676183B2 (en) | 1997-03-06 |
CA2138008A1 (en) | 1993-12-23 |
EP0646032A4 (en) | 1996-03-06 |
JPH07507944A (en) | 1995-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5738657A (en) | Ambulatory energized container system | |
AU700372B2 (en) | Apparatus and methods for multiple fluid infusion | |
US5672167A (en) | Controlled release osmotic pump | |
AU634481B2 (en) | Portable infusion device assembly | |
EP0223763B1 (en) | An artificial gland for implantation in the human body | |
US5312389A (en) | Osmotically driven syringe with programmable agent delivery | |
US5553741A (en) | Liquid delivery device | |
US4066556A (en) | Fluid filter and method of making same | |
US5085656A (en) | Implantable device for the dosed administration of medicaments to the human body | |
EP0702968B1 (en) | Accordion container for chemical | |
US20150352271A1 (en) | Medical device | |
JPH08257140A (en) | Embedding type infusion pump | |
JPS61355A (en) | Container for bicarbonate-containing solution | |
JPS63164962A (en) | Pressure injection apparatus | |
JPS6334351B2 (en) | ||
EP0646032A1 (en) | Ambulatory energized container system | |
JPH11164885A (en) | Continuous drug solution injector | |
KR102070393B1 (en) | A Fluid Bag with a Pressure Bag including A plurality of unit space cells | |
US6544250B1 (en) | Blind clinical trial device | |
KR102412854B1 (en) | A Fluid Bag Pressing Device with a Pressure Bag | |
US6391001B1 (en) | Intravenous line flushing device | |
JPH1147235A (en) | Multi-chamber container | |
AU727879B2 (en) | Drug delivery means | |
JPS61176360A (en) | Body mounting pump housing and pump assembly using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 1994 331583 Country of ref document: US Date of ref document: 19941102 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1993916549 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2138008 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 1993916549 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 1996 769822 Country of ref document: US Date of ref document: 19961219 Kind code of ref document: A |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1993916549 Country of ref document: EP |